Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Feb 8, 2016 · 10-Q · 39 days after period end · 0001615774-16-004126
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Net Income | -$3.95M | -$786.72K | $358.64K | -$453.52K |
| EPS Diluted | -$0.12 | -$0.06 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Feb 8, 2016 · 39 d after period end
